Back to Search Start Over

1083P A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab (pembro) in checkpoint inhibitor refractory advanced or unresectable melanoma.

Authors :
Shoushtari, A.N.
Olszanski, A.J.
Nyakas, M.
Hornyak, T.J.
Wolchok, J.D.
Levitsky, V.
Møller, A-S.
Kuryk, L.
Risberg Handeland, K.
Jäderberg, M.
Source :
Annals of Oncology. 2021 Supplement 5, Vol. 32, pS897-S898. 2p.
Publication Year :
2021

Details

Language :
English
ISSN :
09237534
Volume :
32
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152689553
Full Text :
https://doi.org/10.1016/j.annonc.2021.08.1468